Skip to content

Unilateral vs Bilateral Application of Muscle Energy Techniques in Pelvic Somatic Dysfunction

Novel Applications of the Pubic Muscle Energy Technique for Pelvic Somatic Dysfunctions Against Their Standard Treatment Modalities.

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06266650
Acronym
PMEOMT
Enrollment
100
Registered
2024-02-20
Start date
2024-10-30
Completion date
2025-09-30
Last updated
2024-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Somatic Dysfunction

Brief summary

The goal of this clinical trial is to compare the efficacy of pelvic muscle energy technique online against the traditional full length osteopathic pelvic treatment protocol. The main question it aims to answer are • Can one single pelvic muscle energy technique can correct all pelvic somatic dysfunctions (SD)? Participants will * be positioned by the physician into the area of treatment into a position of resistance, which is the restrictive barrier. * be instructed to use the targeted muscles for 3-5 seconds in the direction of ease while the physician provides a counterforce. * be instructed to stop contracting their muscles and evaluate the area for decreased tension, then repositions the patient into their new restrictive barrier. * These steps are repeated three to five times and then the dysfunction is reevaluated. Subjects diagnosed with pelvic SD will be divided into two groups. One group will be treated with traditional one and be compared with the pelvic muscle energy group.

Detailed description

Osteopathic muscle energy technique (MET) is a well-known modality widely used by osteopathic practitioners. MET can be applied to different regions and segments of the body, is well tolerated and effective in reducing muscle hypertonicity and pain sensation. MET involves a patient actively using their muscles on request from a precisely controlled position, in a specific direction, against a distinctly executed counter force. The group of pelvic MET consists of specific variations directed to particular somatic dysfunction (SD) of innominate and pubic bones, such as pelvic shears, pelvic outflares and pelvic inflares. All techniques are well known and widely used. Based on empirical clinical observations, not confirmed by any research, it was suggested that pubic abduction/adduction SD MET combination should be able to correct all pelvic SD including innominate SD. The investigators intend to assess if application of abduction/adduction SD combination MET may resolve any one-sided diagnosed pelvic SD. MET involves a patient actively using their muscles on request from a precisely controlled position, in a specific direction, against a distinctly executed counter force. During MET, the physician positions the area of treatment into a position of resistance, which is the restrictive barrier. The physician then instructs the patient to use the targeted muscles for 3-5 seconds in the direction of ease while the physician provides a counterforce. The physician then tells the patient to stop contracting their muscles and evaluate the area for decreased tension, then repositions the patient into their new restrictive barrier. These steps are repeated three to five times and then the dysfunction is reevaluated. Subjects diagnosed with pelvic SD will be divided into two groups. The control group will be treated with traditional one-sided MET, the second group will be treated with combination MET. Results of post-treatment exams will be collected and statistically analyzed.

Interventions

OTHEROsteopathic Treatment Technique- Muscle Energy Treatment

Muscle Energy Treatment involves a patient actively using their muscles on request from a precisely controlled position, in a specific direction, against a distinctly executed counter force. During Muscle Energy Treatment, the physician positions the area of treatment into a position of resistance, which is the restrictive barrier. The physician then instructs the patient to use the targeted muscles for 3-5 seconds in the direction of ease while the physician provides a counterforce. The physician then tells the patient to stop contracting their muscles and evaluate the area for decreased tension, then repositions the patient into their new restrictive barrier. These steps are repeated three to five times and then the dysfunction is reevaluated.

Sponsors

The Touro College and University System
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Subjects diagnosed with pelvic SD will be divided into two groups. One group will be treated with traditional one-sided MET, the second group will be treated with combination MET. Results of post-treatment exams will be collected and statistically analyzed.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Current osteopathic medical students first-and second year.

Exclusion criteria

* Acute severe pelvic pain, * Pregnancy, * History of pelvic trauma or surgery, * Receiving osteopathic treatment for pelvic dysfunction outside this study.

Design outcomes

Primary

MeasureTime frameDescription
Resolution of pelvic somatic dysfunctionThrough treatment completion, on average 30 minutesRestoration of anatomical landmarks symmetry Tested using forward flexion test - Standing upright subject bends forward and motion in sacroiliac joint is evaluated. The side where the investigator's thumb moves farthest is the restricted side. This side will be treated with muscle energry. Resolution will show symmetry between the sacroiliac joints.

Secondary

MeasureTime frameDescription
Anterior anatomical landmarks assessment5 minutesAnterior superior iliac spine symmetry or asymmetry
Posterior anatomical landmarks assessment5 minutesPosterior superior iliac spine symmetry or asymmetry

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026